Related Experiment Video
Updated: Aug 10, 2026
Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 26, 2008
Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features
Klaus Eisendle1, Dominik Wolf, Guenther Gastl
1Laboratory for Tumor and Immunobiology, Division of Hematology and Oncology, Innsbruck Medical University, Innsbruck, Austria. klaus.eisendle@uibk.ac.at
Insights
Dendritic cells (DCs) from chronic myeloid leukemia (CML) patients show functional deficiencies. However, in vitro stimulation can overcome these defects, suggesting potential for CML-DC based anti-leukemic vaccines.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Dendritic cells (DCs) are crucial for initiating immune responses.
- Chronic myeloid leukemia (CML) affects immune cell function.
- CML-derived DCs (CML-DCs) are being investigated for anti-leukemic immunotherapy.
Purpose of the Study:
- To compare the phenotypic and functional characteristics of CML-DCs with those from healthy donors.
- To evaluate the potential of CML-DCs in inducing anti-leukemic immunity.
Main Methods:
- Review of existing literature on CML-DCs.
- Comparison of DC features (phenotype, function) between CML patients and healthy volunteers.
Main Results:
- CML-DCs exhibit significant deficiencies in migration, endocytosis, phagocytosis, antigen processing, maturation, and cytokine production compared to healthy DCs.
- These functional deficits in CML-DCs can be reversed through appropriate in vitro stimulation.
Conclusions:
- CML-DCs possess inherent abnormalities that impair their immune functions.
- Proper generation and maturation protocols for CML-DCs are essential for their effective use in clinical vaccination strategies against leukemia.
Abstract:
Dendritic cells (DCs) are professional antigen-presenting cells playing a pivotal role in the induction of humoral and cellular immune responses, and chronic myeloid leukemia-derived DCs (CML-DCs) are possible candidates for inducing anti-leukemic immunity. This review describes phenotypic and functional features of DCs derived from CML patients as compared with DCs from healthy volunteers. In short, distinct deficiencies have been reported for CML-DCs, such as reduced migration, endocytosis, phagocytosis, antigen processing, DC maturation and cytokine production. DC abnormalities of CML patients can be abrogated by proper in vitro stimulation of leukemic DCs. This underscores the importance of proper generation and maturation of CML-DCs when considering clinical vaccination protocols.
More Related Videos
08:31Characterization of Human Monocyte-derived Dendritic Cells by Imaging Flow Cytometry: A Comparison between Two Monocyte Isolation Protocols
Published on: October 18, 2016
09:04Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
Published on: March 28, 2025
